Search results for Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade
Showing 1 – 10 of1products
ID: BAB556180016
Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade, ProteoGenix, PX-TA1346
Description of Ontuxizumab Biosimilar - Anti-CD248 mAb - Research Grade General information on Anti-CD248[Homo sapiens] (Ontuxizumab) Monoclonal Antibody Ontuxizumab monoclonal antibody targets CD248. It has been used in the treatment of cancer.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.